Syndax is hiring for 3 jobs on Simplify. Start your career today.

Syndax

Develops targeted cancer therapies and immunotherapies

Biotechnology

Company Overview

Syndax Pharmaceuticals specializes in developing innovative cancer therapies, including SNDX-5613 and axatilimab, utilizing targeted therapies and immunotherapies to improve outcomes for cancer patients.

Biotechnology

Company Stage

IPO

Total Funding

$759.5M

Founded

2005

Headquarters

Waltham, Massachusetts

Growth & Insights

Headcount

6 month growth

↑ 14%

1 year growth

↑ 76%

2 year growth

↑ 176%